Scientists may have discovered a drug that can help patients with Alzheimer's disease. The drug named solanezumab can slow down the rate of memory loss in patients suffering from mild Alzheimer's. In a study, 1,300 patients having mild dementia were grouped into two and given different kind of drugs. One group has been made to take the solanezumab drug and the other patients took a placebo. The trial which lasted for 18 months showed that patients under the solanezumab treatment experienced a 30% decline in memory loss. To validate the results, the researchers also placed the placebo group under the solanezumab treatment. The patients also displayed similar improvements which is a sign that the drug can deliver genuine impact on the development
Alzheimer’s disease is the 6th leading cause of death in the United States (Help End Alzheimer's.). It is a common form of dementia categorized by a progressive decline in cognitive function (Simmons-Stern, 2010). According to the Alzheimer’s Association, “More than 500,000 seniors die each year because they have Alzheimer's disease”. Therefore Alzheimer’s disease kills more people than prostate and breast cancer together (Help End Alzheimer's.) Although there is no cure or treatment to slow the progression of Alzheimer's disease it can be treated with medication, memory activities, and music therapy. The main classification of medication that is used for Alzheimer disease is Cholinesterase inhibitors. A noninvasive and inexpensive
Unfortunately, there is no cure for Alzheimer’s disease. Instead, it’s prolonged through medications. Referring once again to the NIA’s Alzheimer’s disease fact sheet, medications such as donepezil and memantine among others are used to ward off the effects of the disease. However, these drugs only seem to work for a limited time, and for some, they don’t at all.
Alzheimer’s disease affects the lives of over 5 million Americans today. The cost that it has placed on the U.S is a staggering $203 million dollars. Researchers have reported that those numbers are expected to triple by 2050. However draining that this disease may seem, the real question is whether there is a solution. To this day there is still no cure to stop or even slow down th progression of the brain disease but there are treatments that help cover the symptoms. While the majority of the people who suffer from Alzheimer is generally over the age of 65, about 200,000, of the estimated 5 million, are in the age range of 30-40.
Dementia is a progressive process, with the symptoms and decline in function often worsening, sometimes rapidly, overtime. Although the elderly population are most frequently affected, many younger patients can also be affected. Currently, no cure, be it medical or behavioural, has been isolated, however certain treatments have proved beneficial in delaying the onset or staying off further rapid deterioration. In addition to pharmaceutical treatment modalities, other support and managerial techniques may enable n enhanced quality of life.
Burcham and Rosentheal (2016) talk about a medication called Aricept. Aricept is a cholinesterase inhibitor that was approved by the FDA to treat early stages of Alzheimer's disease. Cholinesterase inhibitors prevent the breakdown of acetylcholine, a chemical in the brain and the body that helps to communicate with other cells in the body. For AD patients, Aricept would increase the amount of acetylcholine and improve the function of neuron that have not been destroyed. Furthermore, Aricept does not cure the disease, it helps delaying the disease and preventing symptoms form becoming worse.
Some medications can help slow down the process of Alzheimer’s disease. There is currently only five drugs that can do that. Each drug
There is no cure for Alzheimer’s. But drug and non-drug treatments may help with both cognitive and behavioral symptoms
In the aftermath of the pharmaceutical company Eli Lilly’s announcement that their drug (Solanezumab) may actually inhibit memory loss in people with Alzheimer’s, several authoritative scientists called for more testing.
Dementia, defined by the Alzheimer’s Association, is the overall term for diseases and conditions characterized by a decline in memory or other thinking skills that affects a person’s ability to perform everyday activities. More than 250,000 Americans will develop dementia (including Alzheimer 's) when they are sixty-five or older and at eighty-five the risk of developing Alzheimer’s is fifty percent. Since this disease was found in 1907 by Alois Alzheimer, there have been thousands of dollars, research, and clinical trials put into finding a cure for this horrible disease. This literature review examines the effects of the type of Dementia known as
Thank you for sharing your thoughts with us. Alzheimer’s disease (AD) is a progressive cognitive disease mostly affect the aging people, but it is not cause because of age. “A common misperception is that AD is a normal or expected occurrence of aging, and that it is part of the typical trajectory of age-related cognitive decline” ( Burock, & Naqvi, 2014, p. 36). The medications these people are taking on daily basis are to stop the progression of the disease instead of improve cognitive function. This is an irreversible. Whatever part of the brain that is already affected will not come back to the previous state. Alzheimer's drugs don't work for everyone, and they can't cure the disease. Over time, their effects wear off. Regine,
Alzheimer’s disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills, and eventually the ability to carry out the simplest tasks. To date, it is officially ranked as the sixth leading cause of death in the United States; however, recent estimates indicate that the disorder may actually rank third, just behind heart disease and cancer, as a cause of death for older people. Alzheimer’s, also known as senile dementia, is predominantly the most common cause of dementia among older adults. Dementia is the loss of cognitive functioning and behavioral abilities, particularly thinking, remembering, and reasoning, to such an extent that it interferes with an
Current pharmacological treatment options available to Alzheimer's patients provide only modest and short-acting benefits in exchange for
With the growing number of people becoming diagnosed, and experiencing symptoms of Alzheimer’s disease, we must begin to take precautions and somehow attempt to gain knowledge of how the disease can be better treated, and ultimately prevented.
Alzheimer's Disease is a condition that affects 50% of the population over the age of eighty five, which equals four million Americans each year. It is becoming an important and high-profile issue in today's society for everyone. There are rapid advancements being made in the fight against this disease now more than ever, and the purpose of this essay is to educate the public on the background as well as the new discoveries. There are many new drugs that are being tested and studied every day which slow down, and may even halt the progress of the disease.
Alzheimer’s is a life-threating disease that affects many elderly. This tragic disease affects parts of the brain, severely damaging and hampering the neurons. However, researcher are continually searching for a cure for this disease.